Klimapharm Technologies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 22 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.72 Cr
- Revenue Growth 199.25%
- Profit Growth 74.80%
- Ebitda 20.14%
- Net Worth 140.59%
- Total Assets 22.57%
About Klimapharm Technologies
Klimapharm Technologies Private Limited (KTPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 January 2018 (Seven years 22 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.72 Cr.
Noureen Matte, Noorsaba Shaikh, and Neha Momin serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999MH2018PTC304748
- Company No.
304748
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jan 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Klimapharm Technologies?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Noureen Matte  | Director | 31-Jan-2018 | Current |
| Noorsaba Shaikh | Director | 31-Jan-2018 | Current |
| Neha Momin | Director | 31-Jan-2018 | Current |
Financial Performance of Klimapharm Technologies.
Klimapharm Technologies Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 199.25% increase. The company also saw a substantial improvement in profitability, with a 74.8% increase in profit. The company's net worth Soared by an impressive increase of 140.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Klimapharm Technologies?
Unlock access to Klimapharm Technologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹67.21 M
₹0
Charges Breakdown by Lending Institutions
- Others : 6.72 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Aug 2024 | Others | ₹3.05 Cr | Open |
| 31 Mar 2023 | Others | ₹2.92 M | Open |
| 27 Jul 2022 | Others | ₹6.34 M | Open |
| 27 Jul 2022 | Others | ₹3.95 M | Open |
| 02 Jul 2022 | Others | ₹2.35 Cr | Open |
How Many Employees Work at Klimapharm Technologies?
Klimapharm Technologies has a workforce of 26 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Klimapharm Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Klimapharm Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.